Cargando…
Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion
OBJECTIVE: Ceramide is a signaling molecule that contributes to insulin resistance and hepatosteatosis. In the present study, we activated de novo ceramide synthesis by inducing the hepatic expression of Sptlc2 to investigate the role of ceramide in glucose and lipid metabolism. METHODS: We first co...
Autores principales: | Kim, Goon-Tae, Kim, Su-Jung, Park, Si-Hyun, Lee, Dongyup, Park, Tae-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379091/ https://www.ncbi.nlm.nih.gov/pubmed/32821738 http://dx.doi.org/10.12997/jla.2020.9.2.291 |
Ejemplares similares
-
Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response
por: Kim, Goon-Tae, et al.
Publicado: (2022) -
Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis
por: Kuo, Andrew, et al.
Publicado: (2022) -
Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD
por: Ijuin, Sho, et al.
Publicado: (2022) -
Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis
por: Li, Chunyu, et al.
Publicado: (2023) -
Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion
por: Sundaram, Meenakshi, et al.
Publicado: (2010)